Researchers at the University of Pennsylvania and other institutions found a similar degree of visual improvement using systemic anti-inflammatory medicine and a time-release implant placed surgically inside the eye.
Results of this study, the Multicenter Uveitis Steroid Treatment Trial, are published online in the journal Ophthalmology.
Related Articles on Eye Diseases:
Researchers Find New Genetic Cause for Retinitis Pigmentosa
Study: Patients With Retinal Disease More Likely to Suffer Strokes
10 Statistics and Facts About Ophthalmology and Ophthalmologists
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.